Furthermore, hyperglycemia impairs skeletal muscle cell insulin sensitivity (55–58), pancreatic β-cell insulin secretory capacity (59, 60), and endothelial cell function (61, 62) within in vitro experimental models. The gene discussed is INS; the disease is Hyperglycemia.